Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Shares

31 Mar 2021 07:00

RNS Number : 9583T
Zoetic International PLC
31 March 2021
 

For immediate release

31 March 2021

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310 

 

Zoetic International plc

('Zoetic' or the 'Company')

 

Issue of Shares

Holding in Company

 

Zoetic, the international CBD group, has received an exercise notice from Mr John Story to exercise today the full conversion rights on the £330,000 convertible loan note issued by the Company, originally announced on 12 February 2020 (the "Loan Note"). The Loan Note was convertible at a price of 6 pence per ordinary share of 1 pence each ("Ordinary Shares"), and was capable of exercise by Mr Story, in his sole discretion, at any time. As a result, the Company has today issued 5,500,000 new Ordinary Shares to Mr Story (the "Conversion Shares") and the liability of the Loan Note has been extinguished.

 

Application will be made to the London Stock Exchange for the Conversion Shares to be admitted to trading on the Main Market of the London Stock Exchange and the Standard Segment of the FCA Official List ("Admission"). It is expected that Admission will become effective and that dealings in the Conversion Shares on the Main Market of the London Stock Exchange will commence on or around 7 April 2021.

 

On Admission, the Company will have 202,070,034 Ordinary Shares in issue, each with one voting right. There are no shares held in treasury. Therefore, the Company's total number of Ordinary Shares and voting rights will be 202,070,034 and this figure may be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Following Admission, and to the best of the Company's knowledge, Mr Story will have a total interest in 27,512,221 Ordinary Shares, equivalent to the 13.62 per cent of issued Ordinary Shares. Mr Story has agreed not to dispose of the Conversion Shares for a period of one year from today (the "Period"), unless the Ordinary Shares trade at a minimum mid-market closing price for 10 consecutive trading days of not less than 480p at any point during the Period.

 

- Ends -

 

Publication on website

 

A copy of this announcement is also available on the Group's website at www.zoeticinternational.com

 

 

Media enquiries:

Zoetic International plc

c/o Buchanan

Trevor Taylor, Co-CEO

Antonio Russo, Co-CEO

 

 

 

Allenby Capital Limited (Financial Adviser and Broker)

+44 (0) 20 3328 5656

Nick Harriss (Corporate Finance)

 

Nick Naylor (Corporate Finance)

 

Guy McDougall (Equity Sales)

 

 

Buchanan

 

Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz

Tel: +44 (0) 20 7466 5000

zoetic@buchanan.uk.com

www.buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEKBLBXFXLZBBB
Date   Source Headline
24th Nov 20209:00 amRNSPrice Monitoring Extension
24th Nov 20207:00 amRNSLandmark agreement to distribute products
19th Nov 20207:00 amRNSTrading Update
16th Nov 202011:06 amRNSSecond Price Monitoring Extn
16th Nov 202011:00 amRNSPrice Monitoring Extension
16th Nov 20209:05 amRNSSecond Price Monitoring Extn
16th Nov 20209:00 amRNSPrice Monitoring Extension
16th Nov 20207:00 amRNSUpdate on Director Share Purchases
13th Nov 20204:41 pmRNSSecond Price Monitoring Extn
13th Nov 20204:36 pmRNSPrice Monitoring Extension
5th Nov 20207:00 amRNSUpdate on Sale of DTU and Kansas Nitrogen Assets
29th Oct 20207:00 amRNSHolding(s) in Company
28th Oct 20204:00 pmRNSDirectors’ Share Purchases and Share Options
28th Oct 20203:30 pmRNSResult of AGM
28th Oct 20201:30 pmRNSExercise of Share Options
28th Oct 20207:00 amRNSTrading Update
21st Oct 202011:00 amRNSHolding(s) in Company
12th Oct 20204:40 pmRNSSecond Price Monitoring Extn
12th Oct 20204:35 pmRNSPrice Monitoring Extension
9th Oct 202011:05 amRNSSecond Price Monitoring Extn
9th Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSNotice of AGM & Investor Presentation
1st Oct 20204:40 pmRNSSecond Price Monitoring Extn
1st Oct 20204:35 pmRNSPrice Monitoring Extension
30th Sep 20205:40 pmRNSFinal Results for the year ended 31 March 2020
30th Sep 20207:00 amRNSPreliminary Results for the year to 31 March 2020
16th Sep 202010:35 amRNSHolding(s) in Company
11th Sep 20202:05 pmRNSSecond Price Monitoring Extn
11th Sep 20202:00 pmRNSPrice Monitoring Extension
10th Sep 20207:30 amRNSSecond International Distribution Contract Signed
2nd Sep 20207:00 amRNSSale of Colorado Oil and Gas Interests
20th Aug 20204:41 pmRNSSecond Price Monitoring Extn
20th Aug 20204:35 pmRNSPrice Monitoring Extension
20th Aug 20202:00 pmRNSHolding(s) in Company
18th Aug 20202:05 pmRNSSecond Price Monitoring Extn
18th Aug 20202:01 pmRNSPrice Monitoring Extension
17th Aug 20205:30 pmRNSHolding(s) in Company
14th Aug 20202:30 pmRNSHolding(s) in Company
7th Aug 20203:02 pmRNSHolding(s) in Company
7th Aug 20202:05 pmRNSSecond Price Monitoring Extn
7th Aug 20202:00 pmRNSPrice Monitoring Extension
6th Aug 202011:05 amRNSSecond Price Monitoring Extn
6th Aug 202011:00 amRNSPrice Monitoring Extension
5th Aug 20204:00 pmRNSHolding(s) in Company
3rd Aug 20207:00 amRNSUpdate on Sale of DTU and Kansas Nitrogen Assets
23rd Jul 20202:32 pmRNSHolding(s) in Company
22nd Jul 20207:00 amRNSHemp Seed Update
8th Jul 20207:00 amRNSUpdate on Sale of DTU & Kansas Nitrogen Assets
6th Jul 20207:00 amRNSFirst International Distribution Contract
30th Jun 20206:00 pmRNSTotal Voting Rights & Reporting Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.